Wells Fargo’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-160
| Closed | -$2.34K | – | 6508 |
|
|
2024
Q2 | $2.34K | Sell |
160
-1,874
| -92% | -$27.3K | ﹤0.01% | 5607 |
|
|
2024
Q1 | $45.6K | Buy |
2,034
+379
| +23% | +$8.5K | ﹤0.01% | 4918 |
|
|
2023
Q4 | $31.3K | Buy |
1,655
+298
| +22% | +$5.64K | ﹤0.01% | 5030 |
|
|
2023
Q3 | $23.2K | Sell |
1,357
-702
| -34% | -$12K | ﹤0.01% | 5174 |
|
|
2023
Q2 | $61.8K | Buy |
2,059
+1,862
| +945% | +$55.9K | ﹤0.01% | 5046 |
|
|
2023
Q1 | $5.77K | Hold |
197
| – | – | ﹤0.01% | 5695 |
|
|
2022
Q4 | $3.88K | Buy |
197
+1
| +0.5% | +$20 | ﹤0.01% | 5507 |
|
|
2022
Q3 | $6K | Hold |
196
| – | – | ﹤0.01% | 5516 |
|
|
2022
Q2 | $5K | Sell |
196
-993
| -84% | -$25.3K | ﹤0.01% | 5699 |
|
|
2022
Q1 | $53K | Sell |
1,189
-1,497
| -56% | -$66.7K | ﹤0.01% | 5293 |
|
|
2021
Q4 | $103K | Sell |
2,686
-23,258
| -90% | -$892K | ﹤0.01% | 5215 |
|
|
2021
Q3 | $1.32M | Buy |
25,944
+25,762
| +14,155% | +$1.31M | ﹤0.01% | 3806 |
|
|
2021
Q2 | $15K | Buy |
182
+73
| +67% | +$6.02K | ﹤0.01% | 5668 |
|
|
2021
Q1 | $5K | Buy |
109
+18
| +20% | +$826 | ﹤0.01% | 6120 |
|
|
2020
Q4 | $2K | Buy |
91
+1
| +1% | +$22 | ﹤0.01% | 5944 |
|
|
2020
Q3 | $2K | Buy |
90
+5
| +6% | +$111 | ﹤0.01% | 5780 |
|
|
2020
Q2 | $2K | Sell |
85
-658
| -89% | -$15.5K | ﹤0.01% | 5713 |
|
|
2020
Q1 | $11K | Buy |
743
+663
| +829% | +$9.82K | ﹤0.01% | 5443 |
|
|
2019
Q4 | $2K | Hold |
80
| – | – | ﹤0.01% | 5755 |
|
|
2019
Q3 | $2K | Hold |
80
| – | – | ﹤0.01% | 5735 |
|
|
2019
Q2 | $2K | Hold |
80
| – | – | ﹤0.01% | 5714 |
|
|
2019
Q1 | $3K | Buy |
+80
| New | +$3K | ﹤0.01% | 5656 |
|